BR112016020584A2 - Composições de peptídeo auto-organizável - Google Patents
Composições de peptídeo auto-organizávelInfo
- Publication number
- BR112016020584A2 BR112016020584A2 BR112016020584A BR112016020584A BR112016020584A2 BR 112016020584 A2 BR112016020584 A2 BR 112016020584A2 BR 112016020584 A BR112016020584 A BR 112016020584A BR 112016020584 A BR112016020584 A BR 112016020584A BR 112016020584 A2 BR112016020584 A2 BR 112016020584A2
- Authority
- BR
- Brazil
- Prior art keywords
- peptide
- self
- peptide compositions
- organizable
- concentration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Materials For Medical Uses (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461950529P | 2014-03-10 | 2014-03-10 | |
PCT/US2015/019796 WO2015138514A1 (en) | 2014-03-10 | 2015-03-10 | Self-assembling peptide compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112016020584A2 true BR112016020584A2 (pt) | 2017-10-03 |
Family
ID=53008839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016020584A BR112016020584A2 (pt) | 2014-03-10 | 2015-03-10 | Composições de peptídeo auto-organizável |
Country Status (12)
Country | Link |
---|---|
US (3) | US10654893B2 (pt) |
EP (2) | EP3466965A1 (pt) |
JP (3) | JP6628733B2 (pt) |
KR (1) | KR20160127827A (pt) |
CN (2) | CN106459154A (pt) |
AU (2) | AU2015229549B2 (pt) |
BR (1) | BR112016020584A2 (pt) |
CA (1) | CA2939696C (pt) |
DK (1) | DK3116896T3 (pt) |
ES (1) | ES2711728T3 (pt) |
RU (1) | RU2016139369A (pt) |
WO (1) | WO2015138514A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105435211A (zh) | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
AU2013286676B2 (en) | 2012-07-06 | 2016-12-15 | 3-D Matrix, Ltd. | Fill-finish process for peptide solutions |
BR112016020584A2 (pt) | 2014-03-10 | 2017-10-03 | 3 D Matrix Ltd | Composições de peptídeo auto-organizável |
WO2015136370A2 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
CN107406823A (zh) | 2015-02-25 | 2017-11-28 | 立美基股份有限公司 | 用作细胞外基质的合成的肽水凝胶制剂 |
WO2017120092A1 (en) * | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
US20190275196A1 (en) | 2016-06-01 | 2019-09-12 | Eun Seok Gil | Hemostatic Powders with Self-Assembling Peptide Hydrogels |
EP3463495A1 (en) * | 2016-06-01 | 2019-04-10 | 3-D Matrix Ltd. | Hemostatic dressings with self-assembling peptide hydrogels |
WO2018005427A1 (en) | 2016-06-27 | 2018-01-04 | 3-D Matrix, Ltd. | Self-assembling peptide matrix for the prevention of esophageal stricture after endoscopic dissection |
CN111712230B (zh) | 2017-12-15 | 2024-04-26 | 立美基股份有限公司 | 表面活性剂肽纳米结构及在药物递送中的用途 |
US20190287217A1 (en) * | 2018-03-13 | 2019-09-19 | Microsoft Technology Licensing, Llc | Machine learning system for reduced network bandwidth transmission of content |
KR102219828B1 (ko) | 2018-04-11 | 2021-02-24 | 연세대학교 산학협력단 | pH 감응성 펩타이드 구조체, 및 이의 용도 |
WO2020008377A2 (en) | 2018-07-03 | 2020-01-09 | 3-D Matrix, Ltd. | Ionic self-assembling peptides |
CN110396124B (zh) * | 2019-08-21 | 2021-04-13 | 上海交通大学 | 自组装多肽及其作为止血剂的用途 |
CN111848736B (zh) * | 2020-08-05 | 2021-12-31 | 赛克赛斯生物科技股份有限公司 | 自组装多肽、制备方法、自组装多肽制剂及应用 |
KR102647642B1 (ko) * | 2021-05-04 | 2024-03-15 | (주)케어젠 | 혈액 응고 활성을 갖는 펩타이드와 이의 용도 |
EP4384229A1 (en) * | 2021-08-09 | 2024-06-19 | Gel4Med, Inc. | Films formed from self-assembling peptide hydrogels |
US20230381185A1 (en) * | 2022-05-14 | 2023-11-30 | 3-D Matrix, Ltd. | Novel formulations for oral administration of therapeutic agents to the gastrointestinal tract |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
US4466641A (en) | 1982-08-04 | 1984-08-21 | The Lockformer Company | Duct connecting system |
US4642117A (en) | 1985-03-22 | 1987-02-10 | Collagen Corporation | Mechanically sheared collagen implant material and method |
US4947840A (en) | 1987-08-21 | 1990-08-14 | Massachusetts Institute Of Technology | Biodegradable templates for the regeneration of tissues |
US5236903A (en) | 1988-06-24 | 1993-08-17 | Ichiro Azuma | Polypeptide comprising repeated cell-adhesive core sequences |
US5110604A (en) | 1988-06-30 | 1992-05-05 | Collagen Corporation | Processes for producing collagen matrixes and methods of using same |
US5126141A (en) | 1988-11-16 | 1992-06-30 | Mediventures Incorporated | Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides |
US5550187A (en) | 1988-11-21 | 1996-08-27 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
US5629291A (en) | 1992-01-31 | 1997-05-13 | La Jolla Cancer Research Foundation | Methods of modulating fibronectin extracellular matrix assembly |
US5292514A (en) | 1992-06-24 | 1994-03-08 | Minnesota Mining And Manufacturing Company | Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof |
US5955343A (en) | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
US5670483A (en) | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
GB2274988A (en) | 1993-02-10 | 1994-08-17 | Mcconn Stern Rita | Iodine containing wound-healing preparations |
US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5773577A (en) | 1994-03-03 | 1998-06-30 | Protein Polymer Technologies | Products comprising substrates capable of enzymatic cross-linking |
US5527610A (en) | 1994-05-20 | 1996-06-18 | The Uab Research Foundation | Elastomeric polypeptide matrices for preventing adhesion of biological materials |
US5510102A (en) | 1995-01-23 | 1996-04-23 | The Regents Of The University Of California | Plasma and polymer containing surgical hemostatic adhesives |
AU5638096A (en) | 1995-06-07 | 1996-12-30 | Clarion Pharmaceuticals, Inc. | Non-biological patch for hemostasis |
AU726163B2 (en) | 1996-04-04 | 2000-11-02 | Baxter Healthcare Sa | Hemostatic sponge based on collagen |
US6489446B1 (en) | 1996-08-07 | 2002-12-03 | Hsc Research And Development Limited Partnership | Self-aligning peptides modeled on human elastin and other fibrous proteins |
WO1998030252A1 (en) | 1997-01-09 | 1998-07-16 | Cohesion Technologies, Inc. | Methods and apparatuses for making swellable uniformly shaped devices from polymeric materials |
US20030069177A1 (en) | 2000-05-16 | 2003-04-10 | Genentech, Inc. | Method for treating cartilage disorders |
US6224893B1 (en) | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
US6187555B1 (en) | 1998-04-16 | 2001-02-13 | 3M Innovative Properties Company | Spores with increased sensitivity to sterilants using additives that bind to sterilant-sensitive sites |
AU5029599A (en) | 1998-07-06 | 2000-01-24 | Neva Ciftcioglu | Methods for eradication of nanobacteria |
US6046160A (en) | 1999-07-22 | 2000-04-04 | Deroyal Industries, Inc. | Composition and method for enhancing wound healing |
AU2001292609A1 (en) | 2000-09-11 | 2002-03-26 | Closure Medical Corporation | Bronchial occlusion method and apparatus |
HU227987B1 (hu) | 2001-01-25 | 2012-07-30 | Nycomed Pharma As | Szilárd fibrinogént és szilárd trombint tartalmazó hordozó |
US7449180B2 (en) | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
WO2002062969A2 (en) | 2001-02-06 | 2002-08-15 | Massachusetts Institute Of Technology | Cellular reprogramming in peptide hydrogel and uses thereof |
AU2003222167A1 (en) | 2002-04-02 | 2003-10-20 | Northwestern University | Peptide amphiphile solutions and self assembled peptide nanofiber networks |
WO2003096972A2 (en) | 2002-05-13 | 2003-11-27 | Massachusetts Institute Of Technology | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
GB0216286D0 (en) | 2002-07-15 | 2002-08-21 | Univ Leeds | Network |
US20040204561A1 (en) | 2002-08-06 | 2004-10-14 | Ellison Jeffrey J. | Peptide aggregates |
WO2005014615A2 (en) | 2003-06-25 | 2005-02-17 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
US7713923B2 (en) | 2003-06-25 | 2010-05-11 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
JP4950659B2 (ja) | 2003-06-27 | 2012-06-13 | エチコン、インコーポレイテッド | 胎盤組織から由来最多分娩後細胞、及びそれらを作成し使用する方法。 |
US7846891B2 (en) | 2003-10-17 | 2010-12-07 | Massachusetts Institute Of Technology | Self-assembling peptides for regeneration and repair of neural tissue |
GB0404374D0 (en) | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
JP2005263631A (ja) | 2004-03-16 | 2005-09-29 | Sanyo Chem Ind Ltd | 細胞接着性ポリペプチド |
JP5255274B2 (ja) | 2004-07-06 | 2013-08-07 | スリーディー マトリックス, インコーポレイテッド | 精製両親媒性ペプチド組成物およびその使用 |
EP1833504A4 (en) | 2005-01-04 | 2009-08-12 | Brigham & Womens Hospital | PERMANENT DELIVERY OF SELF-ARRANGING PEPTIDE NANOFIBER USING THE PDGF |
US9162005B2 (en) | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
JP5204646B2 (ja) | 2005-04-25 | 2013-06-05 | マサチューセッツ インスティテュート オブ テクノロジー | 止血および他の生理学的活性を促進するための組成物および方法 |
US20060293243A1 (en) | 2005-06-17 | 2006-12-28 | Navneet Puri | Stable, buffered, pharmaceutical compositions including motilin-like peptides |
CN101198350A (zh) | 2005-06-17 | 2008-06-11 | 巴克斯特国际公司 | 含胃动素样肽的稳定的缓冲的药物组合物 |
CA2618184A1 (en) | 2005-06-17 | 2006-12-28 | Baxter International Inc. | Stable buffered, pharmaceutical compositions including motilin-like peptides |
JP4982841B2 (ja) | 2005-10-12 | 2012-07-25 | 国立大学法人名古屋大学 | 再生医療骨組成物 |
JP2009523118A (ja) | 2005-11-14 | 2009-06-18 | ユニバーシティー、オブ、デラウェア | 新規ハイドロゲルおよびそれらの使用 |
AR058567A1 (es) | 2005-12-20 | 2008-02-13 | Bristol Myers Squibb Co | Formulaciones de proteinas estables |
EP1969007B1 (en) | 2005-12-20 | 2013-08-28 | Bristol-Myers Squibb Company | Compositions and methods for producing a composition |
US9095818B2 (en) | 2009-06-15 | 2015-08-04 | Biovec Transfusion, Llc | Method of filtering platelets to remove antiplatelet and anticoagulant agents |
CN101472620A (zh) | 2006-04-25 | 2009-07-01 | 麻省理工学院 | 用于影响污染物、机体流体或其它实体移动和/或影响其它生理状况的组合物和方法 |
EP2066697A2 (en) * | 2006-09-26 | 2009-06-10 | Massachusetts Institute of Technology | Modified self-assembling peptides |
WO2008073395A2 (en) | 2006-12-11 | 2008-06-19 | 3D Matrix, Inc. | Compositions and methods for cardiac tissue protection and regeneration |
CA2680824C (en) | 2007-03-14 | 2018-06-26 | Arch Therapeutics, Inc. | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
AU2008239681B2 (en) | 2007-04-11 | 2013-10-03 | Henry Ford Health System | Cardiac repair, resizing and reshaping using the venous system of the heart |
JP2009011341A (ja) | 2007-06-29 | 2009-01-22 | Yuka Denshi Co Ltd | ペースト状材料充填容器 |
US20090053103A1 (en) | 2007-08-20 | 2009-02-26 | William Patrick Mortimer | Non-linting sterilization packaging material |
ES2534770T3 (es) | 2007-12-05 | 2015-04-28 | 3-D Matrix, Ltd. | Material para la curación de heridas y la reconstrucción de la piel |
US8834926B2 (en) | 2008-08-08 | 2014-09-16 | University Of Delaware | Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels |
CN105435211A (zh) | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
CN101514225B (zh) | 2008-10-13 | 2011-09-14 | 西安蓝晶生物科技有限公司 | 自聚体多肽及其制备方法和应用 |
JP4620804B2 (ja) | 2009-03-09 | 2011-01-26 | 株式会社メニコン | 自己組織化ペプチドおよび高強度ペプチドゲル |
US9439941B2 (en) | 2009-12-14 | 2016-09-13 | The University Of Hong Kong | Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells |
JP5855651B2 (ja) | 2010-07-16 | 2016-02-09 | マサチューセッツ インスティテュート オブ テクノロジー | 改変を組み込んだ自己組織化ペプチドおよびその使用方法 |
JP2012082180A (ja) * | 2010-10-14 | 2012-04-26 | Nagoya Univ | 骨再生用自己組織化ペプチドハイドロゲル |
WO2013030673A2 (en) * | 2011-09-02 | 2013-03-07 | 3-D Matrix, Ltd. | Amphiphilic peptides for thoracic air leakage occlusion |
EP2823830A4 (en) * | 2012-03-09 | 2015-11-18 | 3 D Matrix Ltd | MESH-HIGHNESS MEDIUM |
AU2013286676B2 (en) * | 2012-07-06 | 2016-12-15 | 3-D Matrix, Ltd. | Fill-finish process for peptide solutions |
PL2877497T3 (pl) | 2012-07-27 | 2017-07-31 | Koninklijke Coöperatie Cosun U.A. | Środek strukturyzujący do płynnych detergentów i produktów higieny osobistej |
EP2919826A1 (en) * | 2012-11-14 | 2015-09-23 | 3-D Matrix Ltd. | Vascular embolic system |
CN103251690B (zh) | 2013-02-26 | 2015-10-28 | 中国人民解放军新疆军区联勤部药品仪器检验所 | 维药瘤果黑种草子挥发油在制备治疗慢性阻塞性肺病药物的应用 |
AU2014224200A1 (en) | 2013-03-06 | 2015-08-27 | 3D-Matrix Ltd. | Surgical methods employing purified amphiphilic peptide compositions |
US9724448B2 (en) * | 2013-03-14 | 2017-08-08 | 3-D Matrix, Ltd. | Materials for gastrointestinal obstruction prevention |
US20160030628A1 (en) | 2013-03-14 | 2016-02-04 | 3-D Matrix, Ltd. | Treatment for bile leakage |
ES2756531T3 (es) | 2013-08-22 | 2020-04-27 | Arch Biosurgery Inc | Mallas implantables para controlar el movimiento de fluidos |
ES2842101T3 (es) | 2013-09-02 | 2021-07-12 | Taisei Kako Co | Jeringa y conjunto de jeringa |
WO2015136370A2 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
US20170173105A1 (en) * | 2014-03-10 | 2017-06-22 | 3-D Matrix, Ltd. | Autoassembling peptides for the treatment of pulmonary leakage |
US20170173221A1 (en) * | 2014-03-10 | 2017-06-22 | 3-D Matrix, Ltd. | Self-assembling peptides as bronchial obstruction agents |
BR112016020584A2 (pt) | 2014-03-10 | 2017-10-03 | 3 D Matrix Ltd | Composições de peptídeo auto-organizável |
ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
CA2952777A1 (en) * | 2014-06-20 | 2015-12-23 | 3-D Matrix, Ltd. | Materials and methods for filling bone voids |
WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
IL296772B2 (en) * | 2020-03-31 | 2023-12-01 | 3 D Matrix Ltd | Sterilization of self-assembling peptides by irradiation |
US20230026886A1 (en) * | 2021-07-13 | 2023-01-26 | 10X Genomics, Inc. | Methods for preparing polymerized matrix with controllable thickness |
-
2015
- 2015-03-10 BR BR112016020584A patent/BR112016020584A2/pt not_active IP Right Cessation
- 2015-03-10 EP EP18203220.1A patent/EP3466965A1/en active Pending
- 2015-03-10 JP JP2016556013A patent/JP6628733B2/ja active Active
- 2015-03-10 CA CA2939696A patent/CA2939696C/en active Active
- 2015-03-10 CN CN201580024226.8A patent/CN106459154A/zh active Pending
- 2015-03-10 EP EP15719023.2A patent/EP3116896B1/en active Active
- 2015-03-10 WO PCT/US2015/019796 patent/WO2015138514A1/en active Application Filing
- 2015-03-10 RU RU2016139369A patent/RU2016139369A/ru not_active Application Discontinuation
- 2015-03-10 CN CN202310893326.0A patent/CN117138022A/zh active Pending
- 2015-03-10 DK DK15719023.2T patent/DK3116896T3/en active
- 2015-03-10 AU AU2015229549A patent/AU2015229549B2/en not_active Ceased
- 2015-03-10 US US15/121,251 patent/US10654893B2/en active Active
- 2015-03-10 ES ES15719023T patent/ES2711728T3/es active Active
- 2015-03-10 KR KR1020167028031A patent/KR20160127827A/ko not_active Application Discontinuation
-
2019
- 2019-08-22 AU AU2019219809A patent/AU2019219809A1/en not_active Abandoned
- 2019-12-03 JP JP2019218513A patent/JP2020055836A/ja active Pending
-
2020
- 2020-05-13 US US15/931,073 patent/US20200399310A1/en not_active Abandoned
-
2021
- 2021-10-04 US US17/493,233 patent/US20220033442A1/en active Pending
- 2021-11-08 JP JP2021181679A patent/JP7397042B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2022036947A (ja) | 2022-03-08 |
CA2939696C (en) | 2023-01-10 |
RU2016139369A (ru) | 2018-04-10 |
US20220033442A1 (en) | 2022-02-03 |
CN117138022A (zh) | 2023-12-01 |
US20200399310A1 (en) | 2020-12-24 |
US10654893B2 (en) | 2020-05-19 |
EP3466965A1 (en) | 2019-04-10 |
JP2017510568A (ja) | 2017-04-13 |
JP6628733B2 (ja) | 2020-01-15 |
ES2711728T3 (es) | 2019-05-07 |
US20160362451A1 (en) | 2016-12-15 |
JP2020055836A (ja) | 2020-04-09 |
CA2939696A1 (en) | 2015-09-17 |
DK3116896T3 (en) | 2019-03-18 |
KR20160127827A (ko) | 2016-11-04 |
CN106459154A (zh) | 2017-02-22 |
AU2019219809A1 (en) | 2019-09-12 |
AU2015229549A1 (en) | 2016-08-18 |
AU2015229549B2 (en) | 2019-05-23 |
WO2015138514A1 (en) | 2015-09-17 |
EP3116896A1 (en) | 2017-01-18 |
EP3116896B1 (en) | 2018-12-19 |
JP7397042B2 (ja) | 2023-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016020584A2 (pt) | Composições de peptídeo auto-organizável | |
PH12018501226A1 (en) | Methods for treating huntingtons disease | |
ECSP17043316A (es) | Polvo de coleópteros | |
CO2017005995A2 (es) | Composiciones para el cuidado bucal y métodos de uso | |
BR112016028520A2 (pt) | métodos e composições para o tratamento de transtornos com polipeptídeos de folistatina | |
BR112017003582A2 (pt) | anticorpos, composições e usos | |
BR112016029226A2 (pt) | métodos e composições para o tratamento de úlceras | |
BR112017025574A2 (pt) | composições e métodos para degradação de proteínas de má dobra | |
BR112016024494A2 (pt) | análogos de peptídeo com sonda(s) de aminoácidos ramificados | |
BR112014005144A2 (pt) | preparação e composições de enxofre com valência zero altamente biodisponíveis e seus usos | |
BR112014000466A2 (pt) | polipeptídeos quiméricos e híbridos fator viii, métodos de uso dos mesmos | |
BR112018000632A2 (pt) | moléculas de anticorpo que ligam a cd79 | |
BR112016026359A8 (pt) | métodos para controlar os efeitos ambientais prejudiciais do estrume e para alimentar um animal, embalagem comercial, aditivo alimentar para uma ração animal, aditivo à água potável de um animal, e composição de ração animal | |
PE20171076A1 (es) | Composicion que contiene quitina y proteinas digeribles | |
BR112017004925A2 (pt) | composição e método | |
BR112015022139A2 (pt) | uso de poliésteres com proteção inerente às chamas em adesivos e materiais de vedação | |
BR112019006735A2 (pt) | compostos e métodos para ativação da sinalização de tie2 | |
BR112015018265A2 (pt) | Composições nutricionais contendo um componente peptídico com propriedades estimulantes de adiponectina e utilizações das mesmas | |
BR112014000542A2 (pt) | composições de peroxidase eosinofílica e métodos de uso das mesmas | |
BR112015017797A2 (pt) | celobio-hidrolase termoestável | |
BR112017013453A2 (pt) | novo peptídeo inibidor de pi3ky para o tratamento de doenças do sistema respiratório | |
BR112014028130A2 (pt) | Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos | |
MY193776A (en) | Modified cytotoxins and their therapeutics use | |
BR112019004413A2 (pt) | método para criar um padrão em um material natural de origem humana ou animal, material natural de origem humana ou animal, e, uso de um material natural. | |
BR112017011256A2 (pt) | métodos de preparação de concentrado em suspensão (sc) de pesticida, concentrado em suspensão (sc) de pesticida, e método de semeadura de campo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2661 DE 04-01-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |